The aim of our review is to investigate the role of the BARD1 gene in the assessment of predisposition to breast cancer, which is related to the question of the usefulness of testing this gene in screening programs for families with familial history of breast cancer, and further, to investigate it as a potential target of new anticancer therapies, including sensitivity to chemotherapy. The gene discussed is BARD1; the disease is breast carcinoma.